Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

8.46
Delayed Data
As of 3:59pm ET
 -0.06 / -0.70%
Today’s Change
7.42
Today|||52-Week Range
12.15
-9.03%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$4.8B

Company Description

OPKO Health, Inc. is a diversified healthcare company. It operates through Diagnostics, and Pharmaceutical segments. The Diagnostics segment is consists of the pharmaceutical operates that the company acquired in Chile, Mexico, Ireland, Israel, and Spain and its pharmaceutical research and development operations. The Diagnostics segment is primarily comprised of the clinical and laboratory operations tit acquired through the acquisition of Bio-Reference and OPKO Lab and its point-of-care operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Contact Information

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami Florida 33137
P:(305) 575-4100
Investor Relations:

Employees

Shareholders

Individual stakeholders41.21%
Mutual fund holders12.51%
Other institutional10.98%

Top Executives

Phillip FrostChairman & Chief Executive Officer
Adam E. LogalCFO, Treasurer, & Chief Accounting Officer
Jane H. HsiaoVice Chairman & Chief Technology Officer
Stephen A. StrugnellSenior Director-Scientific Affairs
Douglass H. LaidlawVice President-Medical Affairs